Under the agreement, Synthes has committed to growing Anspach facilities, including the product development and manufacturing capabilities. While Anspach will remain in Florida, Synthes will distribute the products worldwide.
The purchase price of Anspach is not disclosed.
Read the Synthes release on the acquisition.
Read other coverage on Synthes:
– Synthes Reports $907M in Net Sales for 3Q FY 2010
– Court Issued Mixed Ruling in Medtronic’s Appeal of Synthes Patent Dispute
– Synthes Recalling its Synex II Central Body Spinal Implant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
